The Pennant Group (PNTG) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, The Pennant Group, Inc. (PNTG) reported revenue of $219.5 million, up 30.1% over the same period last year. EPS came in at $0.27, compared to $0.24 in the year-ago quarter.The reported revenue represents a surprise of +3.16% over the Zacks Consensus Estimate of $212.78 million. With the consensus EPS estimate being $0.26, the EPS surprise was +3.85%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how The Pennant Group performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Total home health and hospice services: $166.02 million compared to the $162.09 million average estimate based on two analysts. The reported number represents a change of +32.5% year over year.Revenue- Senior living services: $53.48 million versus the two-analyst average estimate of $50.75 million. The reported number represents a year-over-year change of +23.1%.Revenue- Home health and hospice services- Home care and other: $13.06 million compared to the $15.32 million average estimate based on two analysts. The reported number represents a change of +202.4% year over year.Revenue- Home health and hospice services- Hospice: $73.77 million versus the two-analyst average estimate of $71.57 million. The reported number represents a year-over-year change of +24.3%.Revenue- Home health and hospice services- Home health: $79.19 million compared to the $75.16 million average estimate based on two analysts. The reported number represents a change of +28.5% year over year.View all Key Company Metrics for The Pennant Group here>>>Shares of The Pennant Group have returned -14.1% over the past month versus the Zacks S&P 500 composite's +0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Pennant Group, Inc. (PNTG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks